A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00603473 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsies, Partial

Interventions

DRUG: gabapentin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.